LEADER 00716nam0-22002531i-450-
001 990002663020403321
035   $a000266302
035   $aFED01000266302
035   $a(Aleph)000266302FED01
035   $a000266302
100   $a20000920d1971----km-y0itay50------ba
101  1$aENG
200 1 $aCases in Business Finance$fby I.Lew Melnyk and L.Charles Barngrover
210   $aHomewood (Illinois)$cRichard D.Irwin$d1971
700  1$aMelnyk I Lew$0370254
702  1$aBarngrover,$bCharles L.
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990002663020403321
952   $a4-463-TB$bs.i.$fECA
959   $aECA
996   $aCases in Business Finance$9429979
997   $aUNINA
DB    $aING01

LEADER 01399nam  2200409   450 
001 9910707616903321
005 20161017085137.0
035   $a(CKB)5470000002466373
035   $a(OCoLC)960809637
035   $a(OCoLC)995470000002466373
035   $a(EXLCZ)995470000002466373
100   $a20161017d1995      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aCLIA's impact on the availability of laboratory services
210  1$a[Washington, D.C.] :$cDepartment of Health and Human Services, Office of Inspector General,$d1995.
215   $a1 online resource (51 unnumbered pages) $cillustrations
300   $aTitle from title screen (viewed Oct. 14, 2016).
300   $a"June 1995."
300   $a"OEI-05-94-00130."
320   $aIncludes bibliographical references.
517 3 $aClinical Laboratory Improvement Amendments impact on the availability of laboratory services
606   $aMedicare
606   $aMedical laboratories$zUnited States
606   $aDiagnosis, Laboratory$zUnited States
615  0$aMedicare.
615  0$aMedical laboratories
615  0$aDiagnosis, Laboratory
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910707616903321
996   $aCLIA's impact on the availability of laboratory services$93357682
997   $aUNINA